MX2009000513A - Agentes antivirales. - Google Patents

Agentes antivirales.

Info

Publication number
MX2009000513A
MX2009000513A MX2009000513A MX2009000513A MX2009000513A MX 2009000513 A MX2009000513 A MX 2009000513A MX 2009000513 A MX2009000513 A MX 2009000513A MX 2009000513 A MX2009000513 A MX 2009000513A MX 2009000513 A MX2009000513 A MX 2009000513A
Authority
MX
Mexico
Prior art keywords
substituted
carbonylmethyl
methyl
amino
alkyl
Prior art date
Application number
MX2009000513A
Other languages
English (en)
Spanish (es)
Inventor
Ronald Conrad Griffith
Christopher Don Roberts
Franz Ulrich Schmitz
Janos Botyanszki
Son Minh Pham
Original Assignee
Genelabs Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genelabs Tech Inc filed Critical Genelabs Tech Inc
Publication of MX2009000513A publication Critical patent/MX2009000513A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
MX2009000513A 2006-07-14 2007-07-12 Agentes antivirales. MX2009000513A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83104006P 2006-07-14 2006-07-14
PCT/US2007/073391 WO2008008912A1 (en) 2006-07-14 2007-07-12 Antiviral agents

Publications (1)

Publication Number Publication Date
MX2009000513A true MX2009000513A (es) 2009-03-09

Family

ID=38742551

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009000513A MX2009000513A (es) 2006-07-14 2007-07-12 Agentes antivirales.

Country Status (13)

Country Link
EP (1) EP2044083A1 (ru)
JP (1) JP2009543807A (ru)
KR (1) KR20090033881A (ru)
CN (1) CN101490058A (ru)
AR (1) AR062258A1 (ru)
AU (1) AU2007272441A1 (ru)
BR (1) BRPI0714346A2 (ru)
CA (1) CA2657651A1 (ru)
MX (1) MX2009000513A (ru)
PE (1) PE20080427A1 (ru)
RU (1) RU2009105196A (ru)
TW (1) TW200813070A (ru)
WO (2) WO2008008907A2 (ru)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070049593A1 (en) 2004-02-24 2007-03-01 Japan Tobacco Inc. Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor
US7659263B2 (en) 2004-11-12 2010-02-09 Japan Tobacco Inc. Thienopyrrole compound and use thereof as HCV polymerase inhibitor
MX2009011930A (es) 2007-05-04 2009-11-18 Vertex Pharma Terapia de combinacion para el tratamiento de infeccion de virus de hepatitis c.
MX2012006877A (es) 2009-12-18 2012-08-31 Idenix Pharmaceuticals Inc Inhibidores de virus de hepatitis c de arileno o heteroarileno 5, 5 - fusionado.
CA2822357A1 (en) * 2010-12-22 2012-06-28 Abbvie Inc. Hepatitis c inhibitors and uses thereof
US20120252721A1 (en) * 2011-03-31 2012-10-04 Idenix Pharmaceuticals, Inc. Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitor
FR3008975A1 (fr) * 2013-07-23 2015-01-30 Servier Lab Nouveaux derives de pyrrole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
RU2546006C1 (ru) 2014-03-07 2015-04-10 Римма Ильинична Ашкинази Противовирусное средство
EP3248596B1 (en) 2015-01-20 2023-12-06 Tets, Viktor Veniaminovich Hemostatic agent
US10167293B2 (en) * 2016-05-26 2019-01-01 Bayer Pharma Aktiengesellschaft [8-(phenylsulfonyl)-3,8-diazabicyclo[3.2.1]oct-3-yl](1H-1,2,3-triazol-4-yl)methanones
EP3630082A4 (en) 2017-05-24 2021-12-15 Viktor Veniaminovich Tets FRACTIONED ANTIMICROBIAL COMPOSITIONS AND THEIR USE
JP2024513945A (ja) 2021-04-16 2024-03-27 ギリアード サイエンシーズ， インコーポレイテッド チオノピロール化合物
US12070455B2 (en) 2021-09-10 2024-08-27 Gilead Sciences, Inc. Thienopyrrole compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4544857B2 (ja) * 2001-06-11 2010-09-15 ヴァイロケム ファーマ インコーポレイテッド Ｆｌａｖｉｖｉｒｕｓ感染の治療または予防のための化合物および方法
US7304085B2 (en) * 2003-06-04 2007-12-04 Genelabs Technologies, Inc. Nitrogen-containing heteroaryl derivatives

Also Published As

Publication number Publication date
WO2008008912A1 (en) 2008-01-17
PE20080427A1 (es) 2008-06-11
CA2657651A1 (en) 2008-01-17
CN101490058A (zh) 2009-07-22
KR20090033881A (ko) 2009-04-06
BRPI0714346A2 (pt) 2013-03-19
AU2007272441A1 (en) 2008-01-17
JP2009543807A (ja) 2009-12-10
RU2009105196A (ru) 2010-08-27
AR062258A1 (es) 2008-10-29
WO2008008907A3 (en) 2008-03-20
WO2008008907A2 (en) 2008-01-17
EP2044083A1 (en) 2009-04-08
TW200813070A (en) 2008-03-16
AU2007272441A2 (en) 2009-03-19

Similar Documents

Publication Publication Date Title
MX2009000513A (es) Agentes antivirales.
US20060211698A1 (en) Bicyclic heteroaryl derivatives for treating viruses
CA2613261A1 (en) Heteroaryl derivatives for treating viruses
US20070032488A1 (en) 6-Membered aryl and heteroaryl derivatives for treating viruses
JP2010510245A (ja) 抗ウイルス化合物
CA2657788A1 (en) Polycyclic viral inhibitors
WO2007117494A1 (en) Deazapurines useful as inhibitors of janus kinases
KR20100056462A (ko) 항바이러스 화합물, 조성물 및 용도
US20080051384A1 (en) Antiviral agents
US9533999B2 (en) Fused thiazin-3-ones as KCA3.1 inhibitors
US20090197856A1 (en) Antiviral compounds
WO2010081149A1 (en) Anti-viral compounds, compositions, and methods of use

Legal Events

Date Code Title Description
GB Transfer or rights

Owner name: SMITHKLINE BEECHAM CORPORATION

FA Abandonment or withdrawal